Saturday 17 October 2026 Export SRPT’s income statement to Excel — free account

Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, up 15.6% from fiscal 2024. In the quarter to June 2026, revenue fell 34.3%, EPS fell 102.5%, free cash flow fell 14.5% and total debt fell 25.6%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

17.06 0.73 −4.10%

Follow SRPT

Alert me

Market cap: $1.9B
P/E: 0.0×
Fwd P/E: 4.4×
Dividend yield: —
F-score: 3/9
Altman Z: −0.97
Beneish M: −3.41
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	4	6	3	3	+8 more TTM periods Free account
ROE Full definition →	(9.48%)	4.91%	(53.47%)	(21.37%)
ROA Full definition →	(3.98%)	1.96%	(19.51%)	(7.66%)
ROIC Full definition →	(5.64%)	(1.51%)	(42.46%)	(5.26%)
Return on Tangible Assets Full definition →	(6.68%)	3.03%	(39.90%)	(12.57%)
Average Days of Receivables Full definition →	69.66	65.98	66.12	59.84
Free Cash Flow per Share Full definition →	0.71	1.03	(3.15)	(3.88)
Free Cash Flow Full definition →	74.97	108.24	(315.33)	(388.84)
Capital Expenditures Full definition →	(36.04)	(67.04)	(109.85)	(144.20)
Other line items
Cash ROIC Full definition →	2.37%	3.61%	(10.84%)	(12.13%)
Accounts Receivable Turnover Full definition →	4.37	4.14	4.40	5.81
Accounts Payable Turnover Full definition →	8.61	7.16	3.39	5.39
Inventory Turnover Full definition →	0.85	0.83	1.01	0.70
Average Days of Payables Full definition →	23.04	31.68	122.09	59.87
Days of Inventory on Hand Full definition →	408.67	450.67	397.67	685.91
Tax Rate Full definition →	0.04	1.66	0.02	0.08
Research and Development Expense of Revenue Full definition →	39.99%	41.32%	69.24%	57.86%
Selling, General and Administrative Expense of Revenue Full definition →	22.12%	21.38%	22.37%	21.85%
Share Based Compensation of Revenue Full definition →	5.00%	5.10%	5.61%	5.93%
Operating CF/Net income Full definition →	(0.81)	2.69	0.29	0.90
Depreciation/Fixed assets Full definition →	0.13	0.12	0.11	0.11
Capex/Depreciation Full definition →	(0.86)	(1.63)	(2.80)	(3.79)
Revenue per Share Full definition →	18.73	20.80	21.96	24.08
Operating CF per Share Full definition →	1.05	1.67	(2.05)	(2.44)
Capex per Share Full definition →	(0.34)	(0.64)	(1.10)	(1.44)
Capex to Sales Full definition →	0.02	0.03	0.05	0.06

Fold the line items

Columns are period end dates

Stockrow Weekly